Showing posts with label Stigma. Show all posts
Showing posts with label Stigma. Show all posts

Tuesday, May 3, 2011

The Stigma: Why Are Lung Cancer Patients Treated Differently Than Other Cancer Patients?

by Lynne Eldridge MD
Originally Published at About.com on July 12, 2010
Updated July 12, 2010

Being diagnosed with lung cancer carries a certain stigma.

”How long did you smoke?” “I didn’t know you were a closet smoker.” “Too bad he didn’t quit smoking sooner.” Unlike the unconditional support given to those with other forms of cancer, people with lung cancer often feel singled out, like somehow they “deserve” to have cancer. Where does this stigma come from?

Public Perception of a Diagnosis of Lung Cancer

There is a feeling among the general public, that lung cancer is a self-inflicted disease. Smoking is responsible for 80 to 90% of lung cancers, but let’s put this in perspective: Twice as many women die from lung cancer in the United States each year as die from breast cancer, and 20% of these women have never touched a cigarette. Even for those who smoke and develop lung cancer, why do we attach such a stigma to them? Many cancers, and other chronic diseases, are related to lifestyle choices. We don’t seem to judge as harshly those who overeat, are sedentary or sunbathe extensively.

Physicians’ Attitude Regarding Lung Cancer

Physicians are people too, and the bias we see among the public is present in the doctor's office as well. Joan Schiller, MD, the President and Founder of National Lung Cancer Partnership, and a physician who has done a lot of research on the stigma of lung cancer, surveyed primary care physicians in Wisconsin with some saddening results. Though the physicians stated that the type of cancer was not a factor in their referral decisions, results showed that:

  • When hypothetical patients were presented as having advanced cancer, physicians were less likely to refer lung cancer patients to an oncologist than they were to refer breast cancer patients.
  • More physicians were aware that chemotherapy improves survival in advanced breast cancer than with advanced lung cancer.
  • Breast cancer patients were more likely to be referred for further therapy, whereas lung cancer patients were often referred only for symptom control.

Lung Cancer Patient’s Perceived Stigma

Those who are diagnosed with lung cancer experience more embarrassment than those with prostate or breast cancer, and individuals tend to feel stigmatized whether they smoked or not. Some people have even concealed their diagnosis leading to negative financial consequences and lack of social support.

Funding for Lung Cancer Research vs Other Cancers

Sadly, even though lung cancer kills more people than breast cancer, prostate cancer and colon cancer combined, federal funding lags behind. Funding from the private sector also pales in comparison to fund-raising efforts for some other cancers.

Clearly, lung cancer carries a stigma that extends from the government down to the individual. That said, we won’t move forward by pointing the finger and blaming ourselves, physicians, the public and the government. Each of us can make a difference by supporting those with lung cancer as we would support someone with any other form of cancer. Whether you are a lung cancer survivor, the loved one of someone living with lung cancer or a professional working with those with lung cancer, we need to raise awareness. Those living with lung cancer need and deserve our care and support, not an evaluation of the possible causes.


Sources:
- Chapple A, Zieband S, McPherson A. Stigma, shame, and blame experienced by patients with lung cancer: qualitative study2. British Medical Journal. 2004. 328(7454).
- LeConte NK, Else-Quest NM, Eickhoff J, Hyde J, Shiller JH. Assessment of guilt and shame in patients with non-small-cell lung cancer compared with patients with breast and prostate cancer3. Clinical Lung Cancer. 2008. 9(3):171-8.
- Wassenarr TR, Eickhoff JC, Jarzemsky DR, Smith SS, Larson ML, Shiller JH. Differences in primary care clinicians’ approach to non-small cell lung cancer patients compared with breast cancer4. Journal of Thoracic Oncology. 2007. 2(8):722-8.

Wednesday, February 16, 2011

Whether They Smoke or Not, Patients Say Lung Cancer Diagnosis Carries a Social Stigma

The following is a press release from The Oncology Nursing Society (ONS).  ONS is a professional organization of more than 35,000 registered nurses and other healthcare professionals committed to excellence in oncology nursing and to leading the transformation of cancer care by initiating and actively supporting educational, legislative, and public awareness efforts to improve the care of people with cancer. ONS provides nurses and healthcare professionals with access to the highest quality educational programs, cancer care resources, research opportunities, and networks for peer support. Learn more at www.ons.org.
-------
LOS ANGELES, Feb. 11, 2011 (GLOBE NEWSWIRE) -- Patients with lung cancer, whether they smoke or not, feel stigmatized because their disease is strongly associated with smoking, according to a study released today at the Oncology Nursing Society (ONS) 11th National Conference on Cancer Nursing Research. Oncology nurse researcher Janine K. Cataldo, PhD, RN, from the University of California, San Francisco (UCSF) presented the findings.

The purpose of the study was to develop a valid and reliable measure of lung cancer stigma and to compare the relationships of lung cancer stigma to depression and quality of life in smokers and non-smokers. Lung cancer is the leading cause of cancer death for men and women.

One hundred eighty-nine study participants with a lung cancer diagnosis completed online questionnaires. They ranged in age from 20–88 years (mean age = 55 years), 56% were men, 73.8% were partnered, and 14% lived alone. The majority of the participants were Caucasian (85%). Eighty percent of the sample were smokers (current and ex- smokers). Fifty-five percent of the sample met the Center for Epidemiologic Studies Depression Scale criteria for depression. No significant differences in demographic measures between smokers and non-smokers was observed.

In a factor analysis of the Lung Cancer Stigma Scale four factors emerged. The four subscales include stigma/shame, social isolation, discrimination, and smoking. Lung cancer stigma had a strong positive association with depression in smokers and non-smokers, and a strong negative association with quality of life in smokers and non-smokers
"Perceived lung cancer stigma can be described as the person's awareness of their lung cancer as it relates to social disqualification, limitations in opportunities, and negative changes in social identity," Cataldo said. "Perceived stigma can lead to several negative outcomes including increased levels of psychosocial symptoms and increased severity of physical symptoms."
Smokers and non-smokers experience lung cancer stigma, and as a result they also experience more depression and a diminished quality of life. All patients with lung cancer can benefit from an effective lung cancer stigma intervention.

Study funded by UCSF Academic Senate and National Institute of Nursing Research P30.

Wednesday, January 26, 2011

Looking beyond smoking, lung-cancer activists want early detection and treatment

by Laura Ungar
This article originally published as a special to The Washington Post on Monday, January 24, 2011.

After battling lung cancer and losing her sister to the disease, Marilyn Martens likes to hear the public-health community rail against smoking.

But she says anti-tobacco messages can't be the sole weapon against America's deadliest cancer; the focus needs to be widened to better emphasize early detection and treatment, too.

"It's really going to have to be all of these things," said Martens, 52, of Rockville, who underwent surgery for lung cancer in 2008. "I think there's a long way to go."

Martens is one of a growing number of lung cancer survivors, victims' relatives and advocacy groups calling for a greater, more comprehensive focus on the disease - similar to the multi-pronged approach to breast cancer.

Lung cancer killed 158,683 people in 2007, according to the Centers for Disease Control and Prevention. Five-year survival for lung cancer is 15.8 percent, up only slightly from 13 percent 35 years ago.

Doctors said there have been promising developments in treatment and early-detection research in recent years. But awareness of this progress is clouded by the overwhelming role that smoking plays in the disease, many say, an issue reemphasized in a Surgeon General's report last month. The report said that tobacco smoke contains at least 70 chemicals and compounds that cause cancer and that there is no "risk-free level of exposure" to tobacco smoke.

"We have a public-health epidemic that cannot be addressed with stop-smoking alone," said Laurie Fenton-Ambrose, president and chief executive of the Lung Cancer Alliance, a nonprofit advocacy group based in Washington. She said early detection and treatment are also crucial to reducing deaths.

But as they push for more attention to lung cancer, activists face a persistent stigma. "It's hard to digest that lung cancer is seen as the cancer you give yourself," said Martens, who was once a light smoker.

"No one deserves this disease," added Fenton-Ambrose.

Among other obstacles are a dearth of survivors to be voices for the cause and a lack of money. According to the alliance, federal research money for lung cancer from the National Institutes of Health, the Centers for Disease Control and Prevention and the Department of Defense totaled $218 million in 2010, compared with $1.15 billion for breast cancer.

But survivors said they are learning lessons from breast cancer activists and others who have successfully lobbied for money and attention to their causes. And doctors pointed out that there is plenty of overlap: Research on one cancer often leads to developments in others.

Fenton-Ambrose said she's determined that lung cancer comes out of the shadows. "Our movement for lung cancer has just begun," she said.

State governments are spending $517.9 million in fiscal 2011 to discourage the use of tobacco, according to the Campaign for Tobacco-Free Kids. And the CDC recommends that states should spend far more: $3.7 billion. Federal and state governments have also been raising cigarette taxes; the federal tax is now just over a dollar a pack.

Blame and stigma

Despite recent prevention efforts, adult smoking has plateaued in the past several years after dropping from 42 percent in the mid-1960s. The most recent federal numbers show that 20.6 percent of U.S. adults were cigarette smokers in 2009.

Current lung cancer rates reflect past smoking levels, since lung cancer can take many years, even decades, to develop. Up to 85 percent of cases are linked to smoking, medical experts say, although sometimes the cause is unknown and secondhand smoke, radon and asbestos are also culprits.

"One can actually say we have a better knowledge of how to prevent lung cancer than any other cancer," said Otis Brawley, the chief medical officer for the American Cancer Society.

But he said the blame and stigma surrounding the disease is unfair. He said that most people get hooked on cigarettes as impressionable teenagers and that quitting is extremely difficult because nicotine is more addictive than cocaine.

And, he said, those already sickened deserve research that gives them better odds of survival.

"Our approach to lung cancer should not just be anti-smoking research," Brawley said.

Brawley said recent years have brought promising progress on treating the disease. He pointed to Paul Bunn at the University of Colorado Cancer Center outside Denver and his work on lung cancer prognosis and selection of treatment.

Bunn is the principal investigator of his university's specialized program on lung cancer research, which is funded by the National Cancer Institute.

That specialized program is one of a growing number focusing on the disease. In Kentucky, which has the nation's highest rates of lung cancer and ties with West Virginia for the highest smoking rate, a 20-year initiative created by the state legislature funnels a small fraction of the state's tobacco-settlement funds into research. The 1998 multi-state tobacco settlement with tobacco companies has been estimated at $246 billion over the first 25 years. Scientists at the universities of Louisville and Kentucky are working on vaccines for the prevention and treatment of lung cancer, drugs based on novel ways of attacking the disease and new ways of finding it early.

A cure remains distant, scientists said, but early-detection research promises more-immediate benefits. A large study released in November showed that a type of advanced CT imaging can help reduce lung cancer deaths by 20 percent among heavy smokers. The imaging is much more sensitive than the commonly used chest X-ray.

Building momentum

One reason lung cancer remains so deadly is that it's often caught late.

Martens said she was extremely lucky to find her cancer early. Spurred by her sister's diagnosis, with no symptoms except for a tugging in her sternum, Martens had a regular CT scan that found a mass on her left lung. She needed surgery but not chemotherapy or radiation.

"I am the poster child for early detection," Martens said.

Nancy Alvey, a 58-year-old former smoker from Louisville, received a diagnosis of lung cancer about five years ago, after coughing up blood for two days. An X-ray found two spots in and around her right lung. She underwent surgery to remove the upper-right lobe of the lung and several lymph nodes. She suffered infections and needed four rounds of chemotherapy.

Alvey, who is now in remission, agreed with Martens that lung cancer is too often mentioned only in the context of smoking, with early detection and treatment left out of the discussion.

"While smoking is there, it's not the only thing," said Alvey, who works with the Lung Cancer Alliance and has also volunteered to speak with young people about avoiding tobacco. "It's a cancer just like breast cancer, and it deserves the same type of awareness."

Activism for breast cancer offers lessons for those seeking to elevate the cause of lung cancer.

"Our No. 1 strength is our grass-roots network," said Diana Rowden, survivorship and outcomes vice president at Dallas-based Susan G. Komen for the Cure, one of the best-known breast cancer organizations. "That didn't happen overnight. It started at the community level and spread that way."

She said the organization's Race for the Cure has also propelled it forward. The first one was held in 1983 in Dallas and attracted 800 people. In 2010, more than 140 races attracted more than 1.6 million participants worldwide.

"The race is very visible," Rowden said. "People are seeing women are surviving breast cancer and are healthy and active."

Another key is the organization's relationship with corporate partners.

Rowden predicted it wouldn't take decades for the lung cancer movement to reach the level of success of the breast cancer movement because others have helped light a path. She said breast cancer activists learned from AIDS activists who came before them.

Lung cancer activists say their work is starting to pay off.

Fenton-Ambrose said her group now has five state chapters. Among other activities, it has raised more than half a million dollars for research, education, advocacy and treatment through its annual run/walk.

Along with other advocates, the organization pushed for the Defense Department's Lung Cancer Research Program. The initiative was established to promote research on finding, treating and managing early lung cancer after officials concerned about tobacco use among military personnel and about troops' exposure to carcinogens in the field. Congress appropriated $35 million to the program over its first two years, and Fenton-Ambrose hopes an additional $16 million will be appropriated for 2011.

"I think there's a long way to go," said Martens, who has participated in recent lung cancer walks and watched them grow year by year. "But I think there's some momentum."

Ungar is a medical writer at the Courier-Journal in Louisville.

Wednesday, July 14, 2010

A Report from "North of the Border"

Lung cancer patients get little sympathy, study finds
July 09, 2010
http://news.therecord.com
By Johanna Weidner, Record Staff

CAMBRIDGE — Many Canadians have little sympathy for people with lung cancer because of the disease’s link to smoking, according to a new study.

One in five Canadians admit feeling less sympathetic toward lung cancer patients than those with other forms of the disease because of its known association with smoking cigarettes and other tobacco products, reports an international survey by the Global Lung Cancer Coalition.

That lack of concern for people suffering from lung cancer does not surprise Cambridge oncologist Dr. James Gowing.

“Even many physicians have had little sympathy for patients in the past,” said Gowing, who’s also co-chair of the Cancer Advocacy Coalition of Canada.

Unfortunately, that stigma also means there’s less research into the disease to find better treatments that can help people live longer after a lung disease diagnosis. Although the prevalence of lung cancer in Canada is similar to that of breast cancer, lung cancer is four times as deadly.

When Gowing began practicing decades ago, the mortality for breast cancer was much worse than for lung cancer. Now that’s reversed, largely due to the great efforts put into awareness and fundraising for research.

Lung cancer still gets little attention, with few public events or spokespeople even though it’s the leading cause of cancer deaths worldwide.

“I think we need to have a bit more compassion for these poor people,” Gowing said.

And not all people with cancer are smokers. As many as 15 per cent of patients are lifelong non-smokers, and more than a third quit smoking before being diagnosed. Regardless, lung cancer patients often feel guilt and shame because of the stigma.

“They feel neglected. They feel ostracized,” Gowing said. “They’re not receiving any compassion, even among their own family often.”

The study surveyed 16,000 people in 16 countries. Canada ranked among the least sympathetic of all the countries, tying with the United States at 22 per cent reporting less sympathy for people with lung cancer than other forms of cancer and behind only four other nations. The worst was Australia at 29 per cent and the best Argentina at only 10 per cent.

Generally, people in countries with lower rates of smoking were more likely to admit feeling less sympathy for lung cancer patients.

While it is true that lung cancer is mainly caused by smoking, Gowing said, that should not mean lung cancer patients don’t get the same consideration and care as other cancer patients. Rather, more attention should be paid to helping smokers quit and stopping people from starting in the first place.

“We have to do more to prevent people being hooked on cigarette smoke,” he said. “It’s possibly the most addictive substance.”

Gowing hopes this new evidence about the lack of sympathy for lung cancer patients will encourage people to reconsider that negative attitude toward people who are seriously, often fatally, ill.

“They’re human beings and they deserve the same compassion as anybody else.”

Monday, June 21, 2010

Lung Cancer Patients Need Our Support, Not Our Blame

by Bob Riter

There's a warm and fuzzy side to breast cancer. Not the disease itself, which is life-disruptive at its best and deadly at its worst. But there are celebratory races with survivors crossing the finish line, arms raised in triumph; magazine covers honoring celebrities who have survived the disease; and pink ribbons seemingly everywhere.


Other cancers receive less attention. These cancers may not have a warm and fuzzy side, but we agree that people diagnosed with them deserve our support and kindness.


But one cancer is noteworthy for the lack of empathy and compassion it elicits.


"Lung cancer is the ugly stepsister of cancer," was how one person described it to me.


When she was diagnosed, most people assumed that she smoked. She didn't. (Some 10 to 15 percent of people diagnosed with lung cancer are nonsmokers. For reasons not fully understood, lung cancer is more common in nonsmoking women than in nonsmoking men).


Even her friends who knew she didn't smoke interrogated her to find the cause. There was an underlying sense that if she wasn't at fault, someone or something else was.


Blame seems to be the unspoken word when lung cancer is discussed.


People with other cancers aren't blamed. We don't accuse them or even wonder if they did something to cause their cancers. The cancer just is.


Anyone who has had cancer can tell you how difficult it was to get the diagnosis and then to share that news with family and friends. Imagine how much more difficult it would be if you sensed people thinking — or even saying, "Well, that's what you get for smoking."


And, assuming that an individual did smoke, what difference does that make once they have lung cancer? Should we be less compassionate or less supportive? Absolutely not.


I'm hardly an apologist for smokers or for the tobacco industry. I hate it when smokers foul my air and increase my insurance rates.


But if you have lung cancer, you don't need blame. You need kindness and support, given without judgment.


Bob Riter is the Associate Director of the Cancer Resource Center of the Finger Lakes.  This was originally published at theithacajournal.com on June 19th,2010.

Monday, August 24, 2009

Stigma of lung cancer stymies research funds

Little if any revenue from two bills that target tobacco with taxes will go toward detection or cure. Los Angeles Times Opinion By Kim Norris August 24, 2009 - Two bills making their way through the Legislature have the support of many Californians as a legitimate way to help ease the state's budget crisis while also discouraging smoking. One would raise the tobacco tax by $1.50 a pack, and the other would increase it by $2.10. The justification for the tax increase is the negative effect smoking has on public health. I do not object to a tobacco tax. Yet little, if any, of the revenue generated under these bills would actually go toward lung cancer research for early detection and a cure. Under one bill, 85% of the revenue would go to the state's general fund to help with the current fiscal disaster. The remaining 15% would go to a "tobacco tax and health protection fund" that would be used to offset decreases in state funding for various healthcare and school programs -- such as the California Children and Families First Trust Fund, the Hospital Services Account and the Breast Cancer Fund. The other bill calls for revenue to go into a newly created account in the general fund, with money to be allocated for lung cancer research, among other needs, but without specifying how much. Lung cancer, the leading cause of cancer deaths in the United States, kills more people than breast, prostate, colon and pancreatic cancers combined and is considered one of the most significant effects of tobacco use on public health. Yet lung cancer remains the most under-funded and under-researched cancer, resulting in an overall 15% five-year survival rate that has remained virtually unchanged for 40 years, according to the Lung Cancer Alliance. This staggeringly small number becomes amplified when compared with the progress made with other cancers. The overall five-year survival rate for breast cancer, for example, is 88%, and for prostate cancer, it is 99%, according to the American Cancer Society. Because lung cancer still carries the stigma that somehow you brought the disease on yourself, tobacco taxes rather than direct funding remain the perennially popular government source of funding to make up for the shortfalls in general spending. The bottom line is that all cancer victims should be treated equally regardless of personal habits; all cancers are the direct result of genetics, environment and behavior. Do colon cancer patients deserve their disease because they did not get enough fiber in their diet? Should singer Natalie Cole have been denied her new kidney because her old one was damaged by her previous drug use? Of new lung cancer diagnoses, 60% are in nonsmokers, a combination of people who have never smoked and former smokers, many of whom quit decades ago. The former smokers did the right thing for themselves and for society -- they quit. But they are still at risk for lung cancer, and just like lung cancer victims who have never smoked, they will be shocked to discover how few treatment options are available to them. Because of the stigma associated with lung cancer, and because there are relatively few survivors to fight for a cure, lung cancer is one of the least-funded cancers for research in the public and private sectors. In fact, in terms of federal research dollars, lung cancer receives only $1,553 per death. Compare that with $14,400 per breast cancer death, according to the National Cancer Institute. In fact, the NCI has reduced the amount of lung cancer research dollars by 71% since 2005 while increasing breast cancer research dollars by 4% during that same period. I am not suggesting that breast cancer should be denied those research dollars. In fact, the breast cancer community's success is a wonderful example of effective grass-roots advocacy. The Lung Cancer Foundation of America was founded for the purpose of increasing funding for lung cancer research. We support increasing tobacco taxes as long as a fair share of the money, commensurate with lung cancer's effect on public health, is used for lung cancer research. Current public and private funding mostly focuses on prevention, which is only one part of the equation. Early detection and treatment are just as critical, especially because it is estimated that in this year more than 214,000 people in this country will be diagnosed with lung cancer and more than 157,000 will die from it. There are currently no officially agreed-on early detection methods. Once lung cancer becomes symptomatic, it is usually in its late stages, making treatment nearly impossible. What makes lung cancer so insidious is its long incubation period. Even if we were to ban tobacco today but did not develop early detection methods or effective treatments, we would not see a corresponding reduction in lung cancer mortality for another 30 to 40 years. That is too long to wait for lung cancer to receive the attention it so desperately needs. Kim Norris is the president of the Lung Cancer Foundation of America (lcfamerica.org). Copyright © 2009, The Los Angeles Times

Thursday, July 30, 2009

Actress speaks out about stigma of lung cancer

By Michael Petersen, L.A. Daily News To some, Kathryn Joosten is Karen McCluskey of "Desperate Housewives." To others, she's more Mrs. Landingham from "The West Wing." But to others, the Emmy-winning actress is a lung cancer survivor. In 2001, Joosten, a former smoker, underwent surgery to have the cancer removed. The surgery was successful, and now in addition to acting, she spends much of her time speaking about lung cancer. Read the entire article here.

Wednesday, March 4, 2009

Wine Tasting for Joan - Every Saturday in April

If you like a good wine, do not miss the Vino 100 Alpharetta Wine Tasting Events that are held every Saturday from 4:30 p.m. to 6:30 pm. Drop by and sample several featured wines – all for a nominal fee of $10 per person! During the month of April, Vino 100 will donate half of the $10 fee to The Joan Gaeta Lung Cancer Foundation! No RSVP required. Just come by during the times listed above and The Joan Gaeta Lung Cancer Foundation will get a generous donation! Talk wine with Vino 100’s knowledgeable staff, fellow wine lovers, distributors’ reps, and perhaps a vineyard owner from time to time. You’ll enjoy their warm and relaxing ambiance and soothing background jazz music so much, you won't want to leave…and you’ll be helping us in our mission at the same time! Learn more here.

Tuesday, January 20, 2009

Lung Cancer's Double Burden

Patients who smoked feel blame and shame. And nonsmokers feel stigmatized. By Petula Dvorak Washington Post Posted: Tuesday, Jan. 20, 2009 Read it here.

Tuesday, November 11, 2008

They call it "The Invisible Cancer."

Lung cancer often gets pushed to the back of the line by misconceptions from High Point Enterprise, NC via Acquire Media NewsEdge They call it "The Invisible Cancer." It develops and grows quietly, stealthily -- invisibly -- typically causing no noticeable symptoms until it's way too late. Only about 15 percent of those who are diagnosed with the invisible cancer survive even five years. Which begs the obvious question: How can a disease that kills more than 160,000 Americans a year -- making it the deadliest of all cancers -- still be invisible? Shouldn't it be visible by now? Theoretically, yes, lung cancer -- the invisible cancer -- should be more than a mere blip on America's cancer radar. Other forms of the disease -- breast cancer for women, prostate cancer for men, just to name a couple -- tend to grab the headlines, the public sympathy and, not coincidentally, the bulk of research dollars. Meanwhile, those who are diagnosed with lung cancer can scarcely organize a public awareness rally -- much less actively campaign for research funding -- because most of them don't live long enough. And for those who survive, it's tough to garner public support because they can't get past the stigma of lung cancer, which most Americans largely associate with cigarette smoking. "When you have breast cancer or any other type, people swarm around you, they hug you, they say "Oh, I'm so sorry,'" says Charlotte Hummer, a 73-year-old lung cancer survivor who lives in the Davidson County town of Arcadia. "But when you've got lung cancer, it's like, "Oh, you're a smoker, so you deserve it,' and that's a bunch of bull crap." Pardon the coarse language, but Hummer is exactly right about smokers. "Anyone can get lung cancer -- you don't have to be a smoker," says Dr. Jennifer Garst, a Durham lung cancer specialist who is the founding chairwoman of the N.C. Lung Cancer Partnership, a lung cancer advocacy organization. "Smoking is the leading risk factor -- along with exposure to secondhand smoke -- but about 15 percent of those who are diagnosed with lung cancer have never smoked." That's true of survivor Maria Teague, a 40-year-old High Point woman who was diagnosed two years ago with non-small cell adenocarcinoma, or Stage 3 lung cancer. It was also true of David Pardo, also of High Point, who died in January -- at age 45 -- after a two-year battle against lung cancer. Yet for Teague and Pardo, almost everyone who learned of their lung cancer automatically assumed they were smokers. "Up until the very end, the day before David died, doctors were asking, "How long has he smoked?'" recalls Pardo's widow, Anita. "Even the doctors were asking him that. So now, I try to tell everybody that lung cancer is not what you think it is." * * * * Lung cancer may not be what most people think it is, but one thing about the disease is certain -- it kills. In 1971, when then-President Richard Nixon declared his "War on Cancer" with the enactment of the National Cancer Act, lung cancer was the No. 1 cancer killer. Nearly four decades later, though many battles have been won in the war, lung cancer remains the deadliest cancer, accounting for one of every three cancer deaths, according to the Lung Cancer Alliance. An average of 439 people die of lung cancer every day. The disease kills more people than breast, prostate, colon, liver, kidney and melanoma cancers combined. It kills more than three times as many men as prostate cancer and more than twice as many women as breast cancer. The biggest problem, it seems -- the reason for all those deaths -- is the lack of early detection. Only 16 percent of lung cancer is being diagnosed at its earliest and most curable stage, according to the Lung Cancer Alliance. In more than half of the patients diagnosed, the cancer has already metastasized -- spread to other parts of the body -- and many of those patients die within a year of diagnosis. "We don't catch the disease early," Garst says. "We do not have an FDA-approved screening test for lung cancer, and with no screening test, about 70 percent of those with lung cancer are diagnosed with an incurable disease. That's one of the main reasons the survival rate is so low." Would early detection really make that much of a difference? For the answer to that, turn your eyes toward the N.C. House of Representatives, where the House majority leader -- Rep. Hugh Holliman of Lexington -- was just elected to his fifth term in office. Holliman is a two-time lung cancer survivor, having beaten the disease nearly a decade ago and again last year. "Both of mine were caught very, very early, so I had surgery and didn't even need chemo or radiation," Holliman says. "Lung cancer is no different from any other cancer -- if you catch it very early, you're going to be in much better shape." Holliman has anecdotal evidence of that fact. His sister, Nancy Griffin -- whose lung cancer was not detected early -- died from the disease in 1999. * * * * It's the human faces of lung cancer that will make the disease more visible. It's faces such as that of Charlotte Hummer, who was diagnosed with Stage 4 non-small cell lung cancer -- the worst diagnosis possible -- in both lungs. Diagnosed in April 2001, Hummer pressed her doctor to find out how much time she had left. "He said, "You might make it until Christmas,'" she recalls. "Well, Christmas hasn't come yet. This will be my eighth year of celebrating Christmas since I was diagnosed. And the doctor who diagnosed me ... was killed in an automobile accident four years ago. He's gone, and I'm still here." Hummer, of course, is one of the lucky ones. So is Maria Teague, the High Point wife and mother -- and lifelong nonsmoker -- who underwent surgery, four rounds of chemotherapy and 30 radiation treatments for her Stage 3 cancer. The aggressive treatments sapped her strength and claimed her hair, but they worked. Today, Teague is doing wonderfully -- her most recent checkup a couple of weeks ago confirmed that -- but she still thinks about the future. "Not many days go by that I don't think about lung cancer and the possibility of it returning," Teague says. "But you have to come to terms with that, and I've done that now. I have a lot of faith in God -- I'm on His plan." * * * * America needs more survivors such as Hummer and Teague. Unfortunately, there are still too many David Pardo stories. Pardo, a husband and father of two -- and another lifelong nonsmoker -- battled lung cancer for two years before losing the fight on Jan. 19. Positive and upbeat to the very end, Pardo -- a substance-abuse counselor -- continued working until a week before his death. Pardo had participated in a clinical trial, but it didn't help him much. "We asked about more research studies," recalls his widow, Anita, "but they said there weren't any others because there's not enough funding for lung cancer." And therein lies the reason that lung cancer remains the invisible cancer, according to advocates. "Lung cancer has been deprived of research dollars," Garst says. "...We need an early detection test -- that's where a lot of our research needs to be concentrated." According to the Lung Cancer Alliance, the National Cancer Institute's budget for fiscal year 2007 was $4.8 billion, but lung cancer research received less than 5 percent of that total. Meanwhile, the Centers for Disease Control and Prevention last year earmarked $201 million for breast and cervical cancer initiatives, $13.9 million for prostate cancer and $14.4 million for colon cancer. But for lung cancer initiatives? Nothing. "I think it has a lot to do with the stigma, because people think only smokers get lung cancer and they bring it on themselves," says Amy Cipau, president of the N.C. Lung Cancer Partnership. "That's why we call lung cancer the invisible cancer, because you just don't hear enough about it, and people don't know the truth about it. You hear so much about breast cancer and there's so much sympathy for breast cancer -- and that's a good thing -- but we just don't have that same awareness and compassion for lung cancer, and that's what we're trying to change." Copyright (c) 2008, High Point Enterprise, N.C. Distributed by McClatchy-Tribune Information Services. Copyright 2008 Technology Marketing Corporation (TMC) - All rights reserved